Verona Pharma is listed on the portfolio pages of Andera Partners (portfolio page), New Enterprise Associates (portfolio page) and Vivo Capital (portfolio page). Vivo Capital lists it as current; Andera Partners and New Enterprise Associates list it as exited. Andera Partners invested in Verona Pharma in 2016, per Andera Partners' portfolio page. New Enterprise Associates invested in Verona Pharma in 2017, per New Enterprise Associates' portfolio page.
Verona Pharma is a Healthcare, Life Sciences company. Its owner on record, Andera Partners, is a private equity firm. Andera Partners lists 291 companies in the index, 36 of them in Healthcare, Life Sciences. Also backed by New Enterprise Associates and Vivo Capital.
Andera Partners is a private equity asset management firm that invests in companies and their management to support growth and innovation.
Read the Andera Partners profileGlobal venture capital firm investing in technology and healthcare.
Read the New Enterprise Associates profileHealth-care focused investment firm.
Read the Vivo Capital profileVerona Pharma is listed on the portfolio pages of Andera Partners (portfolio page), New Enterprise Associates (portfolio page) and Vivo Capital (portfolio page). Vivo Capital lists it as current; Andera Partners and New Enterprise Associates list it as exited. Andera Partners invested in Verona Pharma in 2016, per Andera Partners' portfolio page. New Enterprise Associates invested in Verona Pharma in 2017, per New Enterprise Associates' portfolio page.
Verona Pharma is in Healthcare, Life Sciences. Classified from the owner's portfolio label.
Andera Partners lists 35 other Healthcare, Life Sciences companies in the index, including Adler Ortho, AgoMab, AM Pharma, Amolyt Pharma and Artios Pharma.
6 of 290 shown
See the full Andera Partners portfolio.
6 of 48 shown
See the full New Enterprise Associates portfolio.
6 of 97 shown
See the full Vivo Capital portfolio.
Browse PE-backed companies.
